Evidence map›Paper›PMID 35310847›Full record

ArticleFrontiers in cellular and infection microbiology2022

Associations Between Vaginal Bacteria and Bacterial Vaginosis Signs and Symptoms: A Comparative Study of Kenyan and American Women.

Kayla A Carter, Jennifer E Balkus, Omu Anzala, Joshua Kimani, Noah G Hoffman, Tina L Fiedler, Vernon Mochache, David N Fredricks, Raymond Scott McClelland, Sujatha Srinivasan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. International journal of systematic and evolutionary microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Profiling of vaginalMicrobial genomics · 2023
    Article
  11. International journal of systematic and evolutionary microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Kayla A CarterDepartment of Epidemiology, University of Washington, Seattle, WA, United States.
Jennifer E BalkusDepartment of Epidemiology, University of Washington, Seattle, WA, United States.
Omu AnzalaDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Joshua KimaniInstitute for Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Noah G HoffmanDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Tina L FiedlerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Vernon MochacheCentre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Raymond Scott McClellandDepartment of Epidemiology, University of Washington, Seattle, WA, United States.
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Fred Hutch Cancer Center · USUniversity of Nairobi · KEUniversity of Washington · USKenya Medical Research Institute · KE

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
The Role of Uncultivated Bacteria in Bacterial VaginosisR01AI061628 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL · 2006 to 2016
$6.6M
Impact of suppressive antimicrobial therapy on the vaginal microbiota and BVR01AI099106 · NIAID · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, RAYMOND SCOTT · 2012 to 2014
$1.8M
Novel Computational Tools for Studying the Human MicrobiomeR01HG005966 · NHGRI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL, MATSEN, FREDERICK ALBERT · 2010 to 2012
$1.5M
NHGRI NIH HHS R01 HG005966NIAID NIH HHS R01 AI061628NIAID NIH HHS R01 AI099106NIAID NIH HHS T32 AI007140
6 · The paper itself

Abstract

Background: Bacterial colonization and associations with bacterial vaginosis (BV) signs and symptoms (Amsel criteria) may vary between populations. We assessed relationships between vaginal bacteria and Amsel criteria among two populations. Methods: Kenyan participants from the placebo arm of the Preventing Vaginal Infections (PVI) trial and participants from a Seattle-based cross-sectional BV study were included. Amsel criteria were recorded at study visits, and the vaginal microbiota was characterized using 16S rRNA gene sequencing. Logistic regression models, accounting for repeat visits as appropriate, were fit to evaluate associations between bacterial relative abundance and each Amsel criterion. Results: Among 84 PVI participants (496 observations) and 220 Seattle participants, the prevalence of amine odor was 25% and 40%, clue cells 16% and 37%, vaginal discharge 10% and 52%, elevated vaginal pH 69% and 67%, and BV 13% and 44%, respectively. BV-associated bacterium 1 (BVAB1) was positively associated with all Amsel criteria in both populations. Conclusions: Core vaginal bacteria are consistently associated with BV signs and symptoms across two distinct populations of women.

Indexed as

Vaginosis, BacterialBacteriaCross-Sectional StudiesFemaleHumansKenyaRNA, Ribosomal, 16SUnited StatesVaginaRNA, Ribosomal, 16SAmsel criteriabacterial vaginosisBVAB1KenyaUnited Statesvaginal microbiota

Identifiers

PMID35310847
PMCPMC8931342
OpenAlexW4214847726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.